Concepedia

John Haanen

JH

Statistics

Publications

4

Citations

291

H-Index

4

Active since

2007

Affiliations

The Netherlands Cancer Institute(Current)

Dutch Cancer Society

University of Utah

John Haanen is an author at The Netherlands Cancer Institute specializing in cancer therapeutics, oncology, and medicine.

Top concepts

Publications per year

2007–2022

4

Publications

4

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Aurélien Marabelle, Robert Hans Ingemar Andtbacka, Kevin J. Harrington et al. · Annals of Oncology · 2018 · 204 citations · Full text

Brain Metastases in Patients With Renal Cell Cancer Receiving New Targeted Treatment

Helgi H. Helgason, Henk Mallo, Helga Droogendijk et al. · Journal of Clinical Oncology · 2007 · 42 citations · Full text

, , +5

558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study

Sumanta Pal, Ben Tran, John Haanen et al. · Regular and Young Investigator Award Abstracts · 2022 · 28 citations · Full text

, , +21

958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors

Andréas Mackensen, Christian Koenecke, John Haanen et al. · 2021 · 17 citations · Full text

, , +25

1–4 of 4